Effect of venoarterial extracorporeal membrane oxygenation initiation timing on tricuspid valve surgery outcomes.

VA-ECMO heart failure tricuspid valve regurgitation

Journal

JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 19 05 2022
revised: 03 02 2023
accepted: 10 02 2023
medline: 10 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

Tricuspid valve surgery is associated with high rates of shock and in-hospital mortality. Early initiation of venoarterial extracorporeal membrane oxygenation after surgery may provide right ventricular support and improve survival. We evaluated mortality in patients undergoing tricuspid valve surgery based on the timing of venoarterial extracorporeal membrane oxygenation. All consecutive adult patients undergoing isolated or combined surgical tricuspid valve repair or replacement from 2010 to 2022 requiring venoarterial extracorporeal membrane oxygenation use were stratified by initiation in the operating room (Early) versus outside of the operating room (Late). Variables associated with in-hospital mortality were explored using logistic regression. There were 47 patients who required venoarterial extracorporeal membrane oxygenation: 31 Early and 16 Late. Mean age was 55.6 years (standard deviation, 16.8), 25 (54.3%) were in New York Heart Association class III/IV, 30 (60.8%) had left-sided valve disease, and 11 (23.4%) had undergone prior cardiac surgery. Median left ventricular ejection fraction was 60.0% (interquartile range, 45-65), right ventricular size was moderately to severely increased in 26 patients (60.5%), and right ventricular function was moderately to severely reduced in 24 patients (51.1%). Concomitant left-sided valve surgery was performed in 25 patients (53.2%). There were no differences in baseline characteristics or invasive measurements immediately before surgery between the Early and Late groups. Venoarterial extracorporeal membrane oxygenation was initiated 194 (23.0-840.0) minutes after cardiopulmonary bypass in the Late venoarterial extracorporeal membrane oxygenation group. In-hospital mortality was 35.5% (n = 11) in the Early group versus 68.8% (n = 11) in the Late group ( Early postoperative initiation of venoarterial extracorporeal membrane oxygenation after tricuspid valve surgery in high-risk patients may be associated with improvement in postoperative hemodynamics and in-hospital mortality.

Identifiants

pubmed: 37425463
doi: 10.1016/j.xjon.2023.02.012
pii: S2666-2736(23)00039-6
pmc: PMC10328813
doi:

Types de publication

Journal Article

Langues

eng

Pagination

171-181

Informations de copyright

© 2023 The Author(s).

Références

Methodist Debakey Cardiovasc J. 2018 Apr-Jun;14(2):110-119
pubmed: 29977467
JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442
pubmed: 30121261
Eur J Cardiothorac Surg. 2012 Nov;42(5):S45-60
pubmed: 23026738
J Cardiothorac Surg. 2019 Jul 4;14(1):129
pubmed: 31272456
Br J Anaesth. 2019 Apr;122(4):428-436
pubmed: 30857599
J Thorac Cardiovasc Surg. 2010 Feb;139(2):302-11, 311.e1
pubmed: 20106393
J Am Heart Assoc. 2017 Jul 28;6(8):
pubmed: 28754654
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Ann Thorac Surg. 2013 Nov;96(5):1546-52; discussion 1552
pubmed: 24070702
J Heart Lung Transplant. 2005 Dec;24(12):2037-42
pubmed: 16364846
ScientificWorldJournal. 2014;2014:393258
pubmed: 24977195
J Thorac Cardiovasc Surg. 2019 Dec;158(6):1576-1584.e3
pubmed: 30948318
J Am Heart Assoc. 2019 May 7;8(9):e012171
pubmed: 31041870
Anaesthesia. 2020 Oct;75(10):1386-1393
pubmed: 32255517
Ann Cardiothorac Surg. 2019 Jan;8(1):116-122
pubmed: 30854320
Korean Circ J. 2019 Aug;49(8):657-677
pubmed: 31364329
Eur Heart J Case Rep. 2020 Apr 24;4(3):1-6
pubmed: 32617486
Eur Heart J. 2019 Feb 1;40(5):476-484
pubmed: 30351406
J Artif Organs. 2021 Mar;24(1):7-14
pubmed: 32926268

Auteurs

Amy Hembree (A)

Division of Cardiac, Thoracic, and Vascular Surgery, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Matthew Lawlor (M)

Division of Cardiology, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Samantha Nemeth (S)

Department of Surgery, Center for Innovation and Outcome Research, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Sivagowry Rasalingam Mørk (SR)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Yuji Kaku (Y)

Division of Cardiac, Thoracic, and Vascular Surgery, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Jessica Spellman (J)

Department of Anesthesiology, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Andrea Miltiades (A)

Department of Anesthesiology, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Paul Kurlansky (P)

Division of Cardiac, Thoracic, and Vascular Surgery, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Koji Takeda (K)

Division of Cardiac, Thoracic, and Vascular Surgery, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Isaac George (I)

Division of Cardiac, Thoracic, and Vascular Surgery, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, NY.

Classifications MeSH